Sancesario G, Iannone M, Morello M, Nisticò G, Bernardi G
Department of Neurology, University of Rome Tor Vergata, Rome, Italy.
Stroke. 1994 Feb;25(2):436-43; discussion 443-4. doi: 10.1161/01.str.25.2.436.
Nitric oxide may influence pathophysiology of brain ischemia in a complex way depending on the sources of its production either from neurons or endothelial cells. We investigated whether inhibition of nitric oxide synthesis affects postischemic neuronal death in hippocampus. Moreover, we evaluated whether the presence of nitric oxide synthase activity in specific neurons protects these against ischemia in the hippocampus, striatum, and sensorimotor cortex.
To inhibit nitric oxide synthase, several dosing regimens of NG-nitro-L-arginine methyl ester (L-NAME) were used (5 or 50 mg/kg IP, twice a day for 4 days, or 30 mg/kg IV) in gerbils. Control animals received either the isomer NG-nitro-D-arginine methyl ester or the vehicle. The gerbils underwent 10-minute occlusion of carotid arteries under ether anesthesia and controlled body temperature while physiological parameters were monitored. Neuronal damage was assessed 5 days after ischemia using Nissl-stained sections of hippocampus. Nitric oxide synthase neurons were histochemically stained for reduced nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase activity.
L-NAME treatments, but not the chronic one at 5 mg/kg, induced elevation of blood pressure (30% to 80% greater than the control level, P < .01), as observed shortly before and after bilateral carotid occlusion. Postischemic neuronal loss in the CA1 through CA4 sectors was worsened by chronic pretreatment with L-NAME at 50 mg/kg (eg, CA1 neuronal counts per 100-microns length: 3.2 +/- 2.74, mean +/- SD; n = 19; P < .01). After the acute (30 mg/kg) or chronic pretreatment at lower dosage (5 mg/kg) with L-NAME, neuronal loss was comparable to that of animals treated with the D-isomer or the vehicle (CA1 counts in vehicle-treated animals: 7.65 +/- 6.51, mean +/- SD; n = 14). None of the L-NAME treatments affected postischemic survival of NADPH diaphorase-positive neurons in hippocampus, striatum, and sensorimotor cortex.
These observations demonstrate that inhibition of endothelial and neuronal nitric oxide synthase activity does not modify resistance of nitric oxide-producing neurons to transient ischemia. The severe inhibition of nitric oxide production aggravates postischemic neuronal death in the hippocampus, whereas the mild inhibition is ineffective.
一氧化氮可能以复杂的方式影响脑缺血的病理生理过程,这取决于其产生的来源是神经元还是内皮细胞。我们研究了一氧化氮合成的抑制是否会影响海马体缺血后神经元的死亡。此外,我们评估了特定神经元中一氧化氮合酶活性的存在是否能保护海马体、纹状体和感觉运动皮层的神经元免受缺血影响。
为抑制一氧化氮合酶,在沙土鼠中使用了几种剂量方案的NG-硝基-L-精氨酸甲酯(L-NAME)(5或50mg/kg腹腔注射,每天两次,共4天,或30mg/kg静脉注射)。对照动物接受异构体NG-硝基-D-精氨酸甲酯或溶剂。在乙醚麻醉和控制体温的条件下,沙土鼠接受10分钟的颈动脉闭塞,同时监测生理参数。缺血5天后,使用海马体的尼氏染色切片评估神经元损伤。对一氧化氮合酶神经元进行组织化学染色,以检测还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH)黄递酶活性。
L-NAME处理(除了5mg/kg的慢性处理)在双侧颈动脉闭塞前后不久观察到血压升高(比对照水平高30%至80%,P<.01)。50mg/kg的L-NAME慢性预处理会使CA1至CA4区域缺血后神经元丢失恶化(例如每100微米长度的CA1神经元计数:3.2±2.74,平均值±标准差;n = 19;P<.01)。在急性(30mg/kg)或较低剂量(5mg/kg)的L-NAME慢性预处理后,神经元丢失与用D-异构体或溶剂处理的动物相当(溶剂处理动物的CA1计数:7.65±6.51,平均值±标准差;n = 14)。L-NAME处理均未影响海马体、纹状体和感觉运动皮层中NADPH黄递酶阳性神经元的缺血后存活。
这些观察结果表明,抑制内皮和神经元一氧化氮合酶活性不会改变产生一氧化氮的神经元对短暂缺血的抵抗力。一氧化氮产生的严重抑制会加重海马体缺血后神经元死亡,而轻度抑制则无效。